answering to Pete:
Study protocol would have to have cross-over design to allow failing patients to be unblinded and cross to another arm of the study ( B arm).
I don't think this trial has such design....I could be wrong
aragon
(1)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links